Trials / Unknown
UnknownNCT02111239
Preoperative Imaging in DIEP Flap Breast Reconstruction
Preoperative Imagining in DIEP Flap Breast Reconstruction: A Randomized Controlled Trial Evaluating Cost and Patient-Reported Outcomes
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether preoperative abdominal imaging using either CT angiogram (CTA), or MR angiogram (MRA) will impact perforator dissection time, cost, and patient outcomes in DIEP flap breast reconstruction.
Detailed description
This study will prospectively compare the clinical, economic and patient outcomes of preoperative imaging using either CTA or MRA with those of no preoperative imaging in patients undergoing deep inferior epigastric perforator (DIEP) flap breast reconstruction. Subjects will randomly undergo either a CTA scan or an MRA scan, or no scan (control) preoperatively. An operative plan based on perforator size and course will be devised by an interventional radiologist and a plastic surgeon. The DIEP flap procedure will be planned for controls. Subjects will not be told if the operative plan is changed intraoperatively. Flap dissection time and changes in operative plan will be recorded intraoperatively and surgeon stress will be evaluated following surgery. Pain and narcotic use will be evaluated preoperatively and on days 1-4 postoperatively. The Breast-Q will be completed preoperatively and at 3 weeks, 3 months and 12 months postoperatively. Groups will be compared in terms of all variables measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CTA | pelvic/abdominal CTA scan |
| DEVICE | MRA | pelvic/abdominal MRA scan |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2014-04-11
- Last updated
- 2016-10-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02111239. Inclusion in this directory is not an endorsement.